1
Acute Effects of GLP-1 on Renal Hemodynamics
Condition(s):The GLP-1-mediated Gut-kidney AxisLast Updated:April 7, 2020Completed
GLP-1: 2340 Clinical Trials, Page 1 of 234
Hide Studies Not Open or Pending
2
GLP-1 REceptor Agonists and Real World EvIdeNce
Condition(s):Type 2 DiabetesLast Updated:May 22, 2019Active, not recruiting
3
Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
Condition(s):Diabetes Mellitus, Type 2Last Updated:July 21, 2020Recruiting
4
Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting
Condition(s):Right Coronary Artery Percutaneous Coronary Intervention; Right Ventricular Diastolic DysfunctionLast Updated:April 11, 2016Unknown status
5
GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
Condition(s):Functional Gastrointestinal DisordersLast Updated:August 9, 2018Completed
6
GLP-1 Receptor Expression in CHI
Condition(s):Congenital HyperinsulinismLast Updated:December 7, 2018Unknown status
7
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Condition(s):GLP-1；Metformin；Telomere-telomerase System；Par-4Last Updated:September 13, 2016Unknown status
8
The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
Condition(s):PrediabetesLast Updated:October 10, 2017Completed
9
GLP-1 Loading During Elective Percutaneous Coronary Intervention
Condition(s):Angina Pectoris; Myocardial Infarction; Reperfusion Injury; Coronary Heart DiseaseLast Updated:June 6, 2018Active, not recruiting
10
GLP-1/Basal Insulin Combination Therapy
Condition(s):Type 2 Diabetes MellitusLast Updated:February 2, 2017Completed